Evidence map›Paper›PMID 32293259›Full record

ArticleBMC molecular and cell biology2020

Characterization of the interactions between Codanin-1 and C15Orf41, two proteins implicated in congenital dyserythropoietic anemia type I disease.

Grace Swickley, Yehoshua Bloch, Lidor Malka, Adi Meiri, Sharon Noy-Lotan, Amiel Yanai, Hannah Tamary, Benny Motro

Open access · goldAbstract read
In one paragraph

Article in BMC molecular and cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mechanism of ASF1 engagement by CDAN1.Nature communications · 2025
    Article
  6. Article
  7. Hereditary disorders of ineffective erythropoiesis.Blood cells, molecules & diseases · 2025
    Review
  8. Mechanism of ASF1 Inhibition by CDAN1.bioRxiv : the preprint server for biology · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Frontiers in physiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Grace SwickleyThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel.
Yehoshua BlochThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel.
Lidor MalkaThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel.
Adi MeiriThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel.
Sharon Noy-LotanHematology/Oncology Department, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Amiel YanaiThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel.
Hannah TamaryHematology/Oncology Department, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.
Benny MotroThe Mina and Everard Goodman faculty of life sciences Bar-Ilan University, 52900, Ramat-Gan, Israel. motro@biu.ac.il.
Bar-Ilan University · ILSchneider Children's Medical Center · IL

Funding

Israel Science Foundation 1981/17
6 · The paper itself

Abstract

backgroundCongenital dyserythropoietic anemia type I (CDA I), is an autosomal recessive disease with macrocytic anemia in which erythroid precursors in the bone marrow exhibit pathognomonic abnormalities including spongy heterochromatin and chromatin bridges. We have shown previously that the gene mutated in CDA I encodes Codanin-1, a ubiquitously expressed and evolutionarily conserved large protein. Recently, an additional etiologic factor for CDA I was reported, C15Orf41, a predicted nuclease. Mutations in both CDAN1 and C15Orf41 genes results in very similar erythroid phenotype. However, the possible relationships between these two etiologic factors is not clear.

resultsWe demonstrate here that Codanin-1 and C15Orf41 bind to each other, and that Codanin-1 stabilizes C15Orf41. C15Orf41 protein is mainly nuclear and Codanin-1 overexpression shifts it to the cytoplasm. Phylogenetic analyses demonstrated that even though Codanin-1 is an essential protein in mammals, it was lost from several diverse and unrelated animal taxa. Interestingly, C15Orf41 was eliminated in the exact same animal taxa. This is an extreme case of the Phylogenetic Profiling phenomenon, which strongly suggests common pathways for these two proteins. Lastly, as the 3D structure is more conserved through evolution than the protein sequence, we have used the Phyre2 alignment program to find structurally homologous proteins. We found that Codanin-1 is highly similar to CNOT1, a conserved protein which serves as a scaffold for proteins involved in mRNA stability and transcriptional control.

conclusionsThe physical interaction and the stabilization of C15Orf41 by Codanin-1, combined with the phylogenetic co-existence and co-loss of these two proteins during evolution, suggest that the major function of the presumptive scaffold protein, Codanin-1, is to regulate C15Orf41 activities. The similarity between Codanin-1 and CNOT1 suggest that Codanin-1 is involved in RNA metabolism and activity, and opens up a new avenue for the study of the molecular pathways affected in CDAI.

Indexed as

Anemia, Dyserythropoietic, CongenitalDeoxyribonucleasesGlycoproteinsHeLa CellsHumansMutationNuclear ProteinsPhylogenyProtein BindingTranscription FactorsCDAN1 protein, humanCNOT1 protein, humanDeoxyribonucleasesGlycoproteinsNuclear ProteinsTranscription FactorsC15Orf41CNOT1Congenital dyserythropoietic anemia type IPhylogenetic profiling

Identifiers

PMID32293259
PMCPMC7092493
OpenAlexW3021196636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.